<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> DOE2-44-0673 </DOCNO><TEXT>In a double-blind study, 49 patients with bone metastases in carcinomaof the prostate were treated with 3 times 75 MBq /sup 89/Sr and salinesolution as placebo, respectively. Analysis after at least 2 years showedthe ineffectiveness of /sup 89/Sr for the relief of pain. Unexpectedly,the study showed a higher life expectancy after treatment with /sup 89/Srwhen comparing both groups (44% versus 12% after two years). An analysisof covariate factors emphasizes the efficiency of /sup 89/Sr on the survivalrate. Early treatment is advisable.</TEXT></DOC>